| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP, Chief Financial Officer | EVP, Chief Financial Officer | Chief Financial Officer
1 company
Mark C. Schneyer is EVP, Chief Financial Officer at ACAD. From February 2022 to October 2026, the filings on record show 0 open-market purchases and 28 sales. Mark C. Schneyer's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $1.5M at current prices.
Our model assigns Mark C. Schneyer a middling insider score of 57/100, based on 28 past trades. Over a 12-month horizon, 50.0% of those trades were profitable, with an average 12-month return of -6.0%.
The ACAD filings lean toward selling, a net 153,455 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 20, 2023 | ACAD Acadia Pharmaceuticals Inc | EVP, Chief Financial Officer | Sale+OE | 5,108 | $22.64 | $115,645.12 | -20.0% | +8.4% | -29.3% | |
| Aug 21, 2023 | ACAD Acadia Pharmaceuticals Inc | EVP, Chief Financial Officer | Sell10b5-1 | 10,000 | $29.00 | $289,970.00 | -38.9% | -24.4% | -48.6% | |
| Jun 8, 2023 | ACAD Acadia Pharmaceuticals Inc | EVP, Chief Financial Officer | Sale+OE | 974 | $25.02 | $24,369.48 | -4.1% | +8.1% | -40.7% | |
| May 17, 2023 | ACAD Acadia Pharmaceuticals Inc | EVP, Chief Financial Officer | Sale+OE | 15,310 | $22.50 | $344,475.00 | -41.1% | +26.6% | -34.5% | |
| Apr 6, 2023 | ACAD Acadia Pharmaceuticals Inc | EVP, Chief Financial Officer | Sale+OE | 1,916 | $18.16 | $34,794.56 | -20.4% | +31.7% | -1.9% | |
| Feb 24, 2023 | ACAD Acadia Pharmaceuticals Inc | EVP, Chief Financial Officer | Sale+OE | 577 | $18.78 | $10,836.06 | -12.3% | +29.2% | +31.0% | |
| Jun 9, 2022 | ACAD Acadia Pharmaceuticals Inc | EVP, Chief Financial Officer | Sale+OE | 653 | $17.91 | $11,694.90 | -16.3% | -3.3% | +41.8% | |
| Feb 23, 2022 | ACAD Acadia Pharmaceuticals Inc | Chief Financial Officer | Sale+OE | 553 | $23.80 | $13,161.40 | -20.8% | -35.3% | -22.6% |